Increased blood neutrophil extracellular traps (NETs) associated with early life stress: translational findings in recent-onset schizophrenia and rodent model

• Published in: Translational psychiatry 2022-12, Vol.12 (1), p.526-11, Article 526
• Main Authors: Corsi-Zuelli, Fabiana, Schneider, Ayda Henriques, Santos-Silva, Thamyris, Loureiro, Camila Marcelino, Shuhama, Rosana, Menezes, Paulo Rossi, Guimarães, Francisco Silveira, Gomes, Felipe Villela, Cunha, Fernando Queiroz, Louzada-Junior, Paulo, Del-Ben, Cristina Marta
• Format: Article
• Language: English
• Subjects: 13/1; 13/106; 13/21; 13/51; 14/63; 631/378; 692/53; 692/53/2421; 692/699/476/1799; 82/80; Animals; Behavioral Sciences; Biological Psychology; Child abuse & neglect; Child development; Extracellular Traps; Interleukin-6; Medicine; Medicine & Public Health; Neurosciences; Neutrophils; Pharmacotherapy; Psychiatry; Rats; Schizophrenia; Stress, Psychological
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-022-02291-4

Higher levels of interleukin (IL)-6 and elevated neutrophil counts are consistently reported in the blood of patients with schizophrenia. Stressors during childhood and/or adolescence are major socioenvironmental risk factors for schizophrenia and may contribute to immune dysregulation. Previous studies using blood cytokines to stratify patients with schizophrenia suggest that only a subset presents a low-grade inflammatory state. However, these studies have not addressed whether environmental factors such as childhood maltreatment contributed to identifying inflammatory clusters. Moreover, a neutrophil-related mechanism (Neutrophil Extracellular Traps; NETs) central to both the initiation and chronicity of autoimmune and inflammatory diseases has never been investigated in psychiatry. Elevated NETs in schizophrenia may predispose patients to inflammatory and autoimmune diseases resulting in reduced life expectancy. We, therefore, investigated NETs as a novel mechanism and biological target in early schizophrenia and their role together with IL-6 and childhood maltreatment in identifying cluster subgroups. We found increased NETs in the plasma of patients with early schizophrenia ( n  = 78) compared to both their unaffected siblings ( n  = 25) and community controls ( n  = 78), irrespective of sex, body mass index, psychoactive drug use, or tobacco smoking. Increased NETs in patients were unrelated to antipsychotic treatment, which was further tested in vitro using fresh neutrophils. By applying unsupervised two-step clustering analysis, we integrated values of NETs, IL-6, and childhood maltreatment scores. We identified two main clusters; childhood maltreatment scores and NETs were the most important variables contributing to cluster separation (high-CL1 and low-CL2), while IL-6 was the least contributor. Patients allocated in the high-CL1 (61.5%) had significantly higher childhood maltreatment scores, NETs, and IL-6 levels than the remaining groups (patients low-CL2, siblings, and controls high-CL1 and low-CL2). We complemented these findings with a rat model based on stress exposure during adolescence that results in several schizophrenia-like changes in adulthood. We found that adolescent stressed rats had higher NETs and IL-6 levels in serum compared to non-stressed rats with a tendency to produce more NETs from the bone marrow. Altogether, this study brings a novel cellular-based mechanism in schizophrenia that, combined with early-stress, could be u